How's the Capital Raise Going to Work?, page-18

I absolutely agree. Something about this biotech has a rare feel. It’s hard to find a biotech with direction, structure and leadership. These guys, as a package, can handle the big time! That’s almost just as important as the therapy working IMO. There’s some pretty bad leadership in the biotech space on the ASX, very few are investment worthy. I’ve noticed lots of biotechs with plenty of irons in the fire, and become a real scattering of a sun of parts. Think of the most successful biotechs out there; NEU, CSL, CUV ect; they have a focus. I believe these guys have the same. Rare chance of SUCCESS!